TY  - JOUR 
AU  - Álvarez-Larrán, Alberto
AU  - Angona, Anna
AU  - Andrade-Campos, Marcio
AU  - Noya Pereira, María Soledad
AU  - Gómez-Casares, María-Teresa
AU  - Cuevas, Beatriz
AU  - Caballero, Gonzalo
AU  - García Hernández, Carmen
AU  - García-Gutiérrez, Valentín
AU  - Palomino, Alicia
AU  - Ferrer-Marín, Francisca
AU  - Mata-Vázquez, María-Isabel
AU  - Moretó, Ana
AU  - Magro, Elena
AU  - Murillo, Ilda
AU  - Alonso Domínguez, Juan M.
AU  - Guerra, José María
AU  - Guerrero, Lucía
AU  - Raya, José-María
AU  - Pérez Encinas, Manuel Mateo
AU  - Carreño-Tarragona, Gonzalo
AU  - Fox, Laura
AU  - Pastor-Galán, Irene
AU  - Bellosillo, Beatriz
AU  - Hernández-Boluda, Juan Carlos
PY  - 2021
UR  - http://hdl.handle.net/20.500.11940/22981
AB  - [EN] The present study assessed the criteria for initiating cytoreduction and response to conventional therapies in 1446 patients with essential thrombocythemia (ET), 267 (17%) of which were CALR-mutated. In low risk patients, time from diagnosis to...
LA  - eng
KW  - Hydroxyurea
KW  - Genotype
KW  - Thrombocythemia, Essential
KW  - Calreticulin
KW  - Spain
KW  - Follow-Up Studies
KW  - Registries
KW  - Mutation, Missense
TI  - Cytoreductive treatment in patients with CALR-mutated essential thrombocythaemia: a study comparing indications and efficacy among genotypes from the Spanish Registry of Essential Thrombocythaemia
DO  - 10.1111/bjh.16988
T2  - British Journal of Haematology
M2  - 988
KW  - citorreducción
KW  - GEMFIN
KW  - CHUAC
KW  - CHUS
VL  - 192
ER  -